{"id":465911,"date":"2010-03-24T09:24:49","date_gmt":"2010-03-24T13:24:49","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=70076"},"modified":"2010-03-24T09:24:49","modified_gmt":"2010-03-24T13:24:49","slug":"fda-ok%e2%80%99s-imdx-h1n1-test","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/465911","title":{"rendered":"FDA OK\u2019s IMDx H1N1 Test"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/Life-Sciences\/\">Life Sciences<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/FDA\/\">FDA<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/h1n1\/\">H1N1<\/a><\/div>\n<p>\t\t<strong>Erin Kutz wrote:<\/strong><\/p>\n<p><a href=\"http:\/\/www.intelligentmdx.com\/\">IntelligentMDx<\/a>, a Cambridge, MA-based maker of molecular diagnostic tests, has garnered FDA emergency use authorization for its product for detecting the H1N1 virus, the company <a href=\"http:\/\/www.intelligentmdx.com\/a389a846-1043-4ca9-ba28-62cff6f0a43d\/news-press-release-detail.htm\">announced<\/a> today. No test has been approved for identifying H1N1, but the emergency use authorization allows the IntelligentMDx diagnostic assay to be used while the flu outbreak is still in emergency status, a state that is set to expire on April 26 of this year, the company said.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/boston\/2010\/03\/24\/fda-oks-imdx-h1n1-test\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20FDA%20OK&#8217;s%20IMDx%20H1N1%20Test%20http:\/\/xconomy.com\/?p=70076\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/boston\/2010\/03\/24\/fda-oks-imdx-h1n1-test\/&#038;t=FDA%20OK&#8217;s%20IMDx%20H1N1%20Test\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/boston\/2010\/03\/24\/fda-oks-imdx-h1n1-test\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=FDA+OK%26%238217%3Bs+IMDx+H1N1+Test&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fboston%2F2010%2F03%2F24%2Ffda-oks-imdx-h1n1-test%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=1bab21ad30c9fef7de3d53366d0b5b60&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=1bab21ad30c9fef7de3d53366d0b5b60&#038;p=1\"\/><\/a><br \/>\n<!-- foo --><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/ixzck91xz7FkDChiaiC3skljOlM\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/ixzck91xz7FkDChiaiC3skljOlM\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/ixzck91xz7FkDChiaiC3skljOlM\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/ixzck91xz7FkDChiaiC3skljOlM\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/xH-bUzLvZVs\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Life Sciences, FDA, H1N1 Erin Kutz wrote: IntelligentMDx, a Cambridge, MA-based maker of molecular diagnostic tests, has garnered FDA emergency use authorization for its product for detecting the H1N1 virus, the company announced today. No test has been approved for identifying H1N1, but the emergency use authorization allows the IntelligentMDx diagnostic assay to be used [&hellip;]<\/p>\n","protected":false},"author":1661,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-465911","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/465911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1661"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=465911"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/465911\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=465911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=465911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=465911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}